BDBM520366 (3R,6R,7R,8E,23S)-6′-Chloro-7-methoxy-11-methoxycarbonyl-13,13-(1,3-propylene)-16,16-dioxo-spiro[21-oxa-16-thia-1,11,15-triazatetracyclo[15.7.2.03,6.020,25]hexacosa[8,17(26),18,20::US11130769, Ex. No. 67

SMILES CO[C@@H]1\C=C\CN(CC2(CCC2)C(=O)NS(=O)(=O)c2ccc3OC[C@]4(CCCc5cc(Cl)ccc45)CN(C[C@@H]4CC[C@@H]14)c3c2)C(=O)OC

InChI Key InChIKey=FXWZHBKYCMOWRU-UHFFFAOYSA-N

Data  1 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 520366   

TargetInduced myeloid leukemia cell differentiation protein Mcl-1(Human)
Prelude Therapeutics

US Patent
LigandPNGBDBM520366(US11130769, Ex. No. 67 | (3R,6R,7R,8E,23S)-6′...)
Affinity DataKi: <100nMAssay Description:The assay was carried out in black half-area 96-well NBS plate (Corning), containing 15 nM of MCL-1 (BPS Bioscience), 5 nM of FITC-Bim and 3-fold ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/8/2022
Entry Details
US Patent